| P2093 | author name string | Ismail Koyuncu | |
| | Feyzullah Besli | |
| | Recep Demirbag | |
| | Zulkif Tanriverdi | |
| | Fatih Gungoren | |
| | Mustafa Begenc Tascanov | |
| | Ataman Gonel | |
| | Muslihittin Emre Erkus | |
| P2860 | cites work | The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality | Q57222590 |
| | Soluble CD40 Ligand in Acute Coronary Syndromes | Q58816350 |
| | CHA2DS2-VASc Score as an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality after Primary PCI in Patients with Acute ST Segment Elevation Myocardial Infarction | Q64249340 |
| | A more meaningful scoring system for determining the severity of coronary heart disease | Q71657544 |
| | Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction | Q73069709 |
| | Membrane-associated CD40L and sCD40L in atherothrombotic disease | Q73906988 |
| | Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes | Q78108701 |
| | Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction | Q83000388 |
| | Erythrocyte sedimentation rate in acute myocardial infarction as a predictor of poor prognosis and impaired reperfusion | Q84880582 |
| | Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction | Q85317125 |
| | Fourth Universal Definition of Myocardial Infarction (2018) | Q91182292 |
| | 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA ... | Q26779649 |
| | Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia | Q33183118 |
| | Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. | Q33183129 |
| | Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. | Q33428261 |
| | 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q34318814 |
| | Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory | Q37330284 |
| | Coronary angiographic scoring systems: an evaluation of their equivalence and validity | Q37552840 |
| | Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach | Q37774756 |
| | Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation | Q37971941 |
| | Thrombosis and acute coronary syndrome | Q37979021 |
| | No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives. | Q38077760 |
| | Soluble CD40L Is a Useful Marker to Predict Future Strokes in Patients With Minor Stroke and Transient Ischemic Attack | Q38410920 |
| | Acute Coronary Syndrome: Focus on Antiplatelet Therapy | Q38717922 |
| | Soluble CD40L: risk prediction after acute coronary syndromes | Q40568978 |
| | The Relation Between No-Reflow Phenomenon and Complete Blood Count Parameters | Q40612721 |
| | No‐Reflow Phenomenon Following Percutaneous Coronary Intervention for Acute Myocardial Infarction: Incidence, Outcome, and Effect of Pharmacologic Therapy | Q42916916 |
| | Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease | Q44403568 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P577 | publication date | 2019-07-15 | |
| P1433 | published in | Medicina | Q26842055 |
| P1476 | title | Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction | |
| P478 | volume | 55 | |